nodes	percent_of_prediction	percent_of_DWPC	metapath
Azathioprine—XDH—Doxorubicin—thyroid cancer	0.443	1	CbGbCtD
Azathioprine—Diverticulitis—Vandetanib—thyroid cancer	0.0213	0.0488	CcSEcCtD
Azathioprine—Intestinal perforation—Vandetanib—thyroid cancer	0.0176	0.0402	CcSEcCtD
Azathioprine—Skin cancer—Sorafenib—thyroid cancer	0.0151	0.0346	CcSEcCtD
Azathioprine—GSTM1—neck—thyroid cancer	0.0146	0.133	CbGeAlD
Azathioprine—HPRT1—saliva-secreting gland—thyroid cancer	0.0117	0.106	CbGeAlD
Azathioprine—Polyp—Vandetanib—thyroid cancer	0.0114	0.0261	CcSEcCtD
Azathioprine—Acute myeloid leukaemia—Epirubicin—thyroid cancer	0.0106	0.0242	CcSEcCtD
Azathioprine—Cyst—Vandetanib—thyroid cancer	0.0104	0.0238	CcSEcCtD
Azathioprine—Interstitial lung disease—Vandetanib—thyroid cancer	0.00983	0.0225	CcSEcCtD
Azathioprine—TPMT—saliva-secreting gland—thyroid cancer	0.00983	0.0896	CbGeAlD
Azathioprine—Acute myeloid leukaemia—Doxorubicin—thyroid cancer	0.00978	0.0224	CcSEcCtD
Azathioprine—Interstitial pneumonia—Sorafenib—thyroid cancer	0.00971	0.0222	CcSEcCtD
Azathioprine—HPRT1—trachea—thyroid cancer	0.00899	0.082	CbGeAlD
Azathioprine—GSTA1—head—thyroid cancer	0.00833	0.0759	CbGeAlD
Azathioprine—HPRT1—thyroid gland—thyroid cancer	0.00711	0.0648	CbGeAlD
Azathioprine—GSTM1—thyroid gland—thyroid cancer	0.00694	0.0633	CbGeAlD
Azathioprine—Colitis—Vandetanib—thyroid cancer	0.00668	0.0153	CcSEcCtD
Azathioprine—Interstitial lung disease—Sorafenib—thyroid cancer	0.00663	0.0152	CcSEcCtD
Azathioprine—HPRT1—head—thyroid cancer	0.00631	0.0575	CbGeAlD
Azathioprine—Neoplasm—Vandetanib—thyroid cancer	0.00629	0.0144	CcSEcCtD
Azathioprine—GSTM1—head—thyroid cancer	0.00616	0.0561	CbGeAlD
Azathioprine—Acute leukaemia—Epirubicin—thyroid cancer	0.00607	0.0139	CcSEcCtD
Azathioprine—GSTA2—head—thyroid cancer	0.00601	0.0548	CbGeAlD
Azathioprine—TPMT—thyroid gland—thyroid cancer	0.006	0.0547	CbGeAlD
Azathioprine—Secondary infection—Epirubicin—thyroid cancer	0.0059	0.0135	CcSEcCtD
Azathioprine—Acute leukaemia—Doxorubicin—thyroid cancer	0.00562	0.0128	CcSEcCtD
Azathioprine—Neoplasm malignant—Sorafenib—thyroid cancer	0.0055	0.0126	CcSEcCtD
Azathioprine—Secondary infection—Doxorubicin—thyroid cancer	0.00546	0.0125	CcSEcCtD
Azathioprine—TPMT—head—thyroid cancer	0.00532	0.0485	CbGeAlD
Azathioprine—HPRT1—lymph node—thyroid cancer	0.00442	0.0403	CbGeAlD
Azathioprine—GSTM1—lymph node—thyroid cancer	0.00431	0.0393	CbGeAlD
Azathioprine—Pancreatitis—Vandetanib—thyroid cancer	0.00428	0.00978	CcSEcCtD
Azathioprine—Neoplasm—Sorafenib—thyroid cancer	0.00424	0.0097	CcSEcCtD
Azathioprine—Pneumonia—Vandetanib—thyroid cancer	0.00391	0.00895	CcSEcCtD
Azathioprine—Hepatic function abnormal—Sorafenib—thyroid cancer	0.0039	0.00891	CcSEcCtD
Azathioprine—Infestation NOS—Vandetanib—thyroid cancer	0.00389	0.0089	CcSEcCtD
Azathioprine—Infestation—Vandetanib—thyroid cancer	0.00389	0.0089	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00386	0.00882	CcSEcCtD
Azathioprine—Hepatic failure—Sorafenib—thyroid cancer	0.00379	0.00867	CcSEcCtD
Azathioprine—TPMT—lymph node—thyroid cancer	0.00373	0.034	CbGeAlD
Azathioprine—Myelosuppression—Epirubicin—thyroid cancer	0.0037	0.00846	CcSEcCtD
Azathioprine—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00368	0.00841	CcSEcCtD
Azathioprine—Haemoglobin—Vandetanib—thyroid cancer	0.00351	0.00803	CcSEcCtD
Azathioprine—Haemorrhage—Vandetanib—thyroid cancer	0.00349	0.00799	CcSEcCtD
Azathioprine—Myelosuppression—Doxorubicin—thyroid cancer	0.00342	0.00782	CcSEcCtD
Azathioprine—Erythema multiforme—Vandetanib—thyroid cancer	0.0033	0.00755	CcSEcCtD
Azathioprine—Mediastinal disorder—Vandetanib—thyroid cancer	0.00315	0.0072	CcSEcCtD
Azathioprine—Arrhythmia—Vandetanib—thyroid cancer	0.00312	0.00714	CcSEcCtD
Azathioprine—Alopecia—Vandetanib—thyroid cancer	0.00309	0.00706	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00307	0.00701	CcSEcCtD
Azathioprine—Pancreatitis—Sorafenib—thyroid cancer	0.00289	0.0066	CcSEcCtD
Azathioprine—Polyp—Epirubicin—thyroid cancer	0.00285	0.00652	CcSEcCtD
Azathioprine—Abdominal discomfort—Sorafenib—thyroid cancer	0.00282	0.00645	CcSEcCtD
Azathioprine—Pneumonia—Sorafenib—thyroid cancer	0.00264	0.00604	CcSEcCtD
Azathioprine—Polyp—Doxorubicin—thyroid cancer	0.00264	0.00603	CcSEcCtD
Azathioprine—Infestation NOS—Sorafenib—thyroid cancer	0.00263	0.006	CcSEcCtD
Azathioprine—Infestation—Sorafenib—thyroid cancer	0.00263	0.006	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.0026	0.00595	CcSEcCtD
Azathioprine—Cyst—Epirubicin—thyroid cancer	0.00259	0.00593	CcSEcCtD
Azathioprine—Arthralgia—Vandetanib—thyroid cancer	0.00259	0.00592	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00257	0.00588	CcSEcCtD
Azathioprine—Bone marrow depression—Epirubicin—thyroid cancer	0.00257	0.00587	CcSEcCtD
Azathioprine—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00248	0.00568	CcSEcCtD
Azathioprine—Infection—Vandetanib—thyroid cancer	0.00247	0.00564	CcSEcCtD
Azathioprine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00243	0.00556	CcSEcCtD
Azathioprine—Skin disorder—Vandetanib—thyroid cancer	0.00241	0.00551	CcSEcCtD
Azathioprine—Cyst—Doxorubicin—thyroid cancer	0.0024	0.00549	CcSEcCtD
Azathioprine—Bone marrow depression—Doxorubicin—thyroid cancer	0.00238	0.00543	CcSEcCtD
Azathioprine—Haemoglobin—Sorafenib—thyroid cancer	0.00237	0.00542	CcSEcCtD
Azathioprine—Haemorrhage—Sorafenib—thyroid cancer	0.00236	0.00539	CcSEcCtD
Azathioprine—Herpes zoster—Epirubicin—thyroid cancer	0.0023	0.00527	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00226	0.00517	CcSEcCtD
Azathioprine—Erythema multiforme—Sorafenib—thyroid cancer	0.00223	0.00509	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00214	0.0049	CcSEcCtD
Azathioprine—Herpes zoster—Doxorubicin—thyroid cancer	0.00213	0.00487	CcSEcCtD
Azathioprine—Immune system disorder—Sorafenib—thyroid cancer	0.00213	0.00487	CcSEcCtD
Azathioprine—Rigors—Epirubicin—thyroid cancer	0.00212	0.00486	CcSEcCtD
Azathioprine—Mediastinal disorder—Sorafenib—thyroid cancer	0.00212	0.00486	CcSEcCtD
Azathioprine—Arrhythmia—Sorafenib—thyroid cancer	0.00211	0.00481	CcSEcCtD
Azathioprine—Alopecia—Sorafenib—thyroid cancer	0.00208	0.00476	CcSEcCtD
Azathioprine—Liver injury—Epirubicin—thyroid cancer	0.00206	0.00471	CcSEcCtD
Azathioprine—Neoplasm malignant—Epirubicin—thyroid cancer	0.00203	0.00464	CcSEcCtD
Azathioprine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00203	0.00464	CcSEcCtD
Azathioprine—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00197	0.00451	CcSEcCtD
Azathioprine—Rigors—Doxorubicin—thyroid cancer	0.00197	0.00449	CcSEcCtD
Azathioprine—Abdominal pain—Vandetanib—thyroid cancer	0.00196	0.00449	CcSEcCtD
Azathioprine—Body temperature increased—Vandetanib—thyroid cancer	0.00196	0.00449	CcSEcCtD
Azathioprine—Liver injury—Doxorubicin—thyroid cancer	0.00191	0.00436	CcSEcCtD
Azathioprine—Anaemia—Sorafenib—thyroid cancer	0.0019	0.00433	CcSEcCtD
Azathioprine—Neoplasm malignant—Doxorubicin—thyroid cancer	0.00188	0.0043	CcSEcCtD
Azathioprine—Leukopenia—Sorafenib—thyroid cancer	0.00184	0.0042	CcSEcCtD
Azathioprine—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00183	0.00418	CcSEcCtD
Azathioprine—Arthralgia—Sorafenib—thyroid cancer	0.00175	0.00399	CcSEcCtD
Azathioprine—Myalgia—Sorafenib—thyroid cancer	0.00175	0.00399	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00173	0.00397	CcSEcCtD
Azathioprine—Hepatocellular injury—Epirubicin—thyroid cancer	0.00173	0.00397	CcSEcCtD
Azathioprine—Diarrhoea—Vandetanib—thyroid cancer	0.0017	0.00388	CcSEcCtD
Azathioprine—Colitis—Epirubicin—thyroid cancer	0.00167	0.00381	CcSEcCtD
Azathioprine—Infection—Sorafenib—thyroid cancer	0.00166	0.0038	CcSEcCtD
Azathioprine—Dizziness—Vandetanib—thyroid cancer	0.00164	0.00375	CcSEcCtD
Azathioprine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00164	0.00375	CcSEcCtD
Azathioprine—Aplastic anaemia—Epirubicin—thyroid cancer	0.00163	0.00372	CcSEcCtD
Azathioprine—Skin disorder—Sorafenib—thyroid cancer	0.00163	0.00372	CcSEcCtD
Azathioprine—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00161	0.00367	CcSEcCtD
Azathioprine—Vomiting—Vandetanib—thyroid cancer	0.00158	0.00361	CcSEcCtD
Azathioprine—Neoplasm—Epirubicin—thyroid cancer	0.00157	0.00358	CcSEcCtD
Azathioprine—Rash—Vandetanib—thyroid cancer	0.00157	0.00358	CcSEcCtD
Azathioprine—Dermatitis—Vandetanib—thyroid cancer	0.00156	0.00357	CcSEcCtD
Azathioprine—Headache—Vandetanib—thyroid cancer	0.00156	0.00355	CcSEcCtD
Azathioprine—Colitis—Doxorubicin—thyroid cancer	0.00154	0.00352	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00153	0.00349	CcSEcCtD
Azathioprine—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00151	0.00344	CcSEcCtD
Azathioprine—Nausea—Vandetanib—thyroid cancer	0.00147	0.00337	CcSEcCtD
Azathioprine—Neoplasm—Doxorubicin—thyroid cancer	0.00145	0.00332	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00145	0.0033	CcSEcCtD
Azathioprine—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00144	0.00329	CcSEcCtD
Azathioprine—Hepatic failure—Epirubicin—thyroid cancer	0.0014	0.0032	CcSEcCtD
Azathioprine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00137	0.00313	CcSEcCtD
Azathioprine—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00133	0.00305	CcSEcCtD
Azathioprine—Abdominal pain—Sorafenib—thyroid cancer	0.00132	0.00303	CcSEcCtD
Azathioprine—Body temperature increased—Sorafenib—thyroid cancer	0.00132	0.00303	CcSEcCtD
Azathioprine—Hepatic failure—Doxorubicin—thyroid cancer	0.0013	0.00296	CcSEcCtD
Azathioprine—Hypersensitivity—Sorafenib—thyroid cancer	0.00123	0.00282	CcSEcCtD
Azathioprine—Diarrhoea—Sorafenib—thyroid cancer	0.00115	0.00262	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00113	0.00259	CcSEcCtD
Azathioprine—Dizziness—Sorafenib—thyroid cancer	0.00111	0.00253	CcSEcCtD
Azathioprine—Pancreatitis—Epirubicin—thyroid cancer	0.00107	0.00244	CcSEcCtD
Azathioprine—Vomiting—Sorafenib—thyroid cancer	0.00106	0.00243	CcSEcCtD
Azathioprine—Rash—Sorafenib—thyroid cancer	0.00106	0.00241	CcSEcCtD
Azathioprine—Dermatitis—Sorafenib—thyroid cancer	0.00105	0.00241	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00105	0.0024	CcSEcCtD
Azathioprine—Headache—Sorafenib—thyroid cancer	0.00105	0.0024	CcSEcCtD
Azathioprine—Pancytopenia—Epirubicin—thyroid cancer	0.00103	0.00236	CcSEcCtD
Azathioprine—Nausea—Sorafenib—thyroid cancer	0.000995	0.00227	CcSEcCtD
Azathioprine—Pancreatitis—Doxorubicin—thyroid cancer	0.000987	0.00226	CcSEcCtD
Azathioprine—Pneumonia—Epirubicin—thyroid cancer	0.000976	0.00223	CcSEcCtD
Azathioprine—Infestation—Epirubicin—thyroid cancer	0.00097	0.00222	CcSEcCtD
Azathioprine—Infestation NOS—Epirubicin—thyroid cancer	0.00097	0.00222	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000962	0.0022	CcSEcCtD
Azathioprine—Pancytopenia—Doxorubicin—thyroid cancer	0.000956	0.00219	CcSEcCtD
Azathioprine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000918	0.0021	CcSEcCtD
Azathioprine—Agranulocytosis—Epirubicin—thyroid cancer	0.000906	0.00207	CcSEcCtD
Azathioprine—Pneumonia—Doxorubicin—thyroid cancer	0.000903	0.00206	CcSEcCtD
Azathioprine—Infestation NOS—Doxorubicin—thyroid cancer	0.000898	0.00205	CcSEcCtD
Azathioprine—Infestation—Doxorubicin—thyroid cancer	0.000898	0.00205	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00089	0.00203	CcSEcCtD
Azathioprine—Haemoglobin—Epirubicin—thyroid cancer	0.000876	0.002	CcSEcCtD
Azathioprine—Haemorrhage—Epirubicin—thyroid cancer	0.000871	0.00199	CcSEcCtD
Azathioprine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000849	0.00194	CcSEcCtD
Azathioprine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000838	0.00192	CcSEcCtD
Azathioprine—Erythema multiforme—Epirubicin—thyroid cancer	0.000824	0.00188	CcSEcCtD
Azathioprine—Haemoglobin—Doxorubicin—thyroid cancer	0.00081	0.00185	CcSEcCtD
Azathioprine—Haemorrhage—Doxorubicin—thyroid cancer	0.000806	0.00184	CcSEcCtD
Azathioprine—Immune system disorder—Epirubicin—thyroid cancer	0.000787	0.0018	CcSEcCtD
Azathioprine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000785	0.00179	CcSEcCtD
Azathioprine—Chills—Epirubicin—thyroid cancer	0.000782	0.00179	CcSEcCtD
Azathioprine—Arrhythmia—Epirubicin—thyroid cancer	0.000778	0.00178	CcSEcCtD
Azathioprine—Alopecia—Epirubicin—thyroid cancer	0.00077	0.00176	CcSEcCtD
Azathioprine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000762	0.00174	CcSEcCtD
Azathioprine—Immune system disorder—Doxorubicin—thyroid cancer	0.000728	0.00166	CcSEcCtD
Azathioprine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000726	0.00166	CcSEcCtD
Azathioprine—Chills—Doxorubicin—thyroid cancer	0.000723	0.00165	CcSEcCtD
Azathioprine—Arrhythmia—Doxorubicin—thyroid cancer	0.00072	0.00165	CcSEcCtD
Azathioprine—Alopecia—Doxorubicin—thyroid cancer	0.000712	0.00163	CcSEcCtD
Azathioprine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000704	0.00161	CcSEcCtD
Azathioprine—Anaemia—Epirubicin—thyroid cancer	0.000701	0.0016	CcSEcCtD
Azathioprine—Malaise—Epirubicin—thyroid cancer	0.000684	0.00156	CcSEcCtD
Azathioprine—Leukopenia—Epirubicin—thyroid cancer	0.000679	0.00155	CcSEcCtD
Azathioprine—TPMT—Metapathway biotransformation—CHST14—thyroid cancer	0.000677	0.0702	CbGpPWpGaD
Azathioprine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000651	0.00149	CcSEcCtD
Azathioprine—Anaemia—Doxorubicin—thyroid cancer	0.000649	0.00148	CcSEcCtD
Azathioprine—Myalgia—Epirubicin—thyroid cancer	0.000646	0.00148	CcSEcCtD
Azathioprine—Arthralgia—Epirubicin—thyroid cancer	0.000646	0.00148	CcSEcCtD
Azathioprine—GSTA2—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000643	0.0667	CbGpPWpGaD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000641	0.00147	CcSEcCtD
Azathioprine—Discomfort—Epirubicin—thyroid cancer	0.000638	0.00146	CcSEcCtD
Azathioprine—Malaise—Doxorubicin—thyroid cancer	0.000633	0.00145	CcSEcCtD
Azathioprine—Leukopenia—Doxorubicin—thyroid cancer	0.000628	0.00144	CcSEcCtD
Azathioprine—Infection—Epirubicin—thyroid cancer	0.000615	0.00141	CcSEcCtD
Azathioprine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000606	0.00139	CcSEcCtD
Azathioprine—Skin disorder—Epirubicin—thyroid cancer	0.000601	0.00137	CcSEcCtD
Azathioprine—Arthralgia—Doxorubicin—thyroid cancer	0.000597	0.00137	CcSEcCtD
Azathioprine—Myalgia—Doxorubicin—thyroid cancer	0.000597	0.00137	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000593	0.00136	CcSEcCtD
Azathioprine—Discomfort—Doxorubicin—thyroid cancer	0.00059	0.00135	CcSEcCtD
Azathioprine—Hypotension—Epirubicin—thyroid cancer	0.000578	0.00132	CcSEcCtD
Azathioprine—Infection—Doxorubicin—thyroid cancer	0.000569	0.0013	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000564	0.00129	CcSEcCtD
Azathioprine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000561	0.00128	CcSEcCtD
Azathioprine—Skin disorder—Doxorubicin—thyroid cancer	0.000556	0.00127	CcSEcCtD
Azathioprine—GSTM1—Metapathway biotransformation—CHST14—thyroid cancer	0.000552	0.0573	CbGpPWpGaD
Azathioprine—Hypotension—Doxorubicin—thyroid cancer	0.000535	0.00122	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000534	0.00122	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000522	0.00119	CcSEcCtD
Azathioprine—Feeling abnormal—Epirubicin—thyroid cancer	0.00051	0.00117	CcSEcCtD
Azathioprine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000506	0.00116	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000494	0.00113	CcSEcCtD
Azathioprine—Body temperature increased—Epirubicin—thyroid cancer	0.000489	0.00112	CcSEcCtD
Azathioprine—Abdominal pain—Epirubicin—thyroid cancer	0.000489	0.00112	CcSEcCtD
Azathioprine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000472	0.00108	CcSEcCtD
Azathioprine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000468	0.00107	CcSEcCtD
Azathioprine—Hypersensitivity—Epirubicin—thyroid cancer	0.000456	0.00104	CcSEcCtD
Azathioprine—Abdominal pain—Doxorubicin—thyroid cancer	0.000453	0.00103	CcSEcCtD
Azathioprine—Body temperature increased—Doxorubicin—thyroid cancer	0.000453	0.00103	CcSEcCtD
Azathioprine—Diarrhoea—Epirubicin—thyroid cancer	0.000423	0.000968	CcSEcCtD
Azathioprine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000422	0.000964	CcSEcCtD
Azathioprine—Dizziness—Epirubicin—thyroid cancer	0.000409	0.000935	CcSEcCtD
Azathioprine—Vomiting—Epirubicin—thyroid cancer	0.000393	0.000899	CcSEcCtD
Azathioprine—Diarrhoea—Doxorubicin—thyroid cancer	0.000392	0.000896	CcSEcCtD
Azathioprine—Rash—Epirubicin—thyroid cancer	0.00039	0.000892	CcSEcCtD
Azathioprine—Dermatitis—Epirubicin—thyroid cancer	0.00039	0.000891	CcSEcCtD
Azathioprine—Headache—Epirubicin—thyroid cancer	0.000388	0.000886	CcSEcCtD
Azathioprine—Dizziness—Doxorubicin—thyroid cancer	0.000379	0.000866	CcSEcCtD
Azathioprine—Nausea—Epirubicin—thyroid cancer	0.000368	0.00084	CcSEcCtD
Azathioprine—Vomiting—Doxorubicin—thyroid cancer	0.000364	0.000832	CcSEcCtD
Azathioprine—Rash—Doxorubicin—thyroid cancer	0.000361	0.000825	CcSEcCtD
Azathioprine—Dermatitis—Doxorubicin—thyroid cancer	0.000361	0.000825	CcSEcCtD
Azathioprine—Headache—Doxorubicin—thyroid cancer	0.000359	0.00082	CcSEcCtD
Azathioprine—Nausea—Doxorubicin—thyroid cancer	0.00034	0.000777	CcSEcCtD
Azathioprine—GSTA1—NRF2 pathway—SLC5A5—thyroid cancer	0.000336	0.0349	CbGpPWpGaD
Azathioprine—GSTA1—NRF2 pathway—RXRA—thyroid cancer	0.000283	0.0293	CbGpPWpGaD
Azathioprine—GSTA1—Biological oxidations—RXRA—thyroid cancer	0.000248	0.0257	CbGpPWpGaD
Azathioprine—GSTA1—NRF2 pathway—NRG1—thyroid cancer	0.000244	0.0254	CbGpPWpGaD
Azathioprine—GSTA2—NRF2 pathway—SLC5A5—thyroid cancer	0.000227	0.0236	CbGpPWpGaD
Azathioprine—GSTM1—NRF2 pathway—SLC5A5—thyroid cancer	0.000221	0.0229	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—MINPP1—thyroid cancer	0.000208	0.0216	CbGpPWpGaD
Azathioprine—TPMT—Biological oxidations—RXRA—thyroid cancer	0.0002	0.0207	CbGpPWpGaD
Azathioprine—GSTA2—NRF2 pathway—RXRA—thyroid cancer	0.000191	0.0198	CbGpPWpGaD
Azathioprine—GSTM1—NRF2 pathway—RXRA—thyroid cancer	0.000186	0.0193	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—MINPP1—thyroid cancer	0.000182	0.0189	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—NDUFA13—thyroid cancer	0.000177	0.0184	CbGpPWpGaD
Azathioprine—GSTA2—Biological oxidations—RXRA—thyroid cancer	0.000167	0.0174	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—CHST14—thyroid cancer	0.000166	0.0173	CbGpPWpGaD
Azathioprine—GSTA2—NRF2 pathway—NRG1—thyroid cancer	0.000165	0.0171	CbGpPWpGaD
Azathioprine—GSTM1—Biological oxidations—RXRA—thyroid cancer	0.000163	0.0169	CbGpPWpGaD
Azathioprine—GSTM1—NRF2 pathway—NRG1—thyroid cancer	0.000161	0.0167	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—NDUFA13—thyroid cancer	0.000155	0.0161	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—MINPP1—thyroid cancer	0.000147	0.0152	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—CHST14—thyroid cancer	0.000146	0.0151	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—PTGS2—thyroid cancer	0.000143	0.0149	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—HPGD—thyroid cancer	0.000134	0.0139	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—CCND1—thyroid cancer	0.00013	0.0135	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—NDUFA13—thyroid cancer	0.000125	0.013	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—MINPP1—thyroid cancer	0.000123	0.0128	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—MINPP1—thyroid cancer	0.00012	0.0124	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—HPGD—thyroid cancer	0.000117	0.0122	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—CHST14—thyroid cancer	0.000117	0.0122	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—NRAS—thyroid cancer	0.000112	0.0116	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—NDUFA13—thyroid cancer	0.000105	0.0109	CbGpPWpGaD
Azathioprine—XDH—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000103	0.0107	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—NDUFA13—thyroid cancer	0.000102	0.0106	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—CHST14—thyroid cancer	9.83e-05	0.0102	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—KRAS—thyroid cancer	9.61e-05	0.00997	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—CHST14—thyroid cancer	9.56e-05	0.00993	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—HPGD—thyroid cancer	9.46e-05	0.00982	CbGpPWpGaD
Azathioprine—XDH—Metabolism—MINPP1—thyroid cancer	8.89e-05	0.00923	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—HRAS—thyroid cancer	8.17e-05	0.00848	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—HPGD—thyroid cancer	7.92e-05	0.00823	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—TPR—thyroid cancer	7.71e-05	0.008	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—HPGD—thyroid cancer	7.71e-05	0.008	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PRKAR1A—thyroid cancer	7.58e-05	0.00787	CbGpPWpGaD
Azathioprine—XDH—Metabolism—NDUFA13—thyroid cancer	7.56e-05	0.00785	CbGpPWpGaD
Azathioprine—XDH—Metabolism—CHST14—thyroid cancer	7.11e-05	0.00738	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—TPR—thyroid cancer	6.74e-05	0.00699	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PRKAR1A—thyroid cancer	6.63e-05	0.00688	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—SLC5A5—thyroid cancer	5.77e-05	0.00599	CbGpPWpGaD
Azathioprine—XDH—Metabolism—HPGD—thyroid cancer	5.73e-05	0.00595	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—TPR—thyroid cancer	5.43e-05	0.00564	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PRKAR1A—thyroid cancer	5.34e-05	0.00555	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—SLC5A5—thyroid cancer	5.04e-05	0.00524	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—RXRA—thyroid cancer	4.85e-05	0.00503	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—TPR—thyroid cancer	4.55e-05	0.00472	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PRKAR1A—thyroid cancer	4.48e-05	0.00465	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—TPR—thyroid cancer	4.43e-05	0.0046	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PRKAR1A—thyroid cancer	4.36e-05	0.00452	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—RXRA—thyroid cancer	4.24e-05	0.0044	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—SLC5A5—thyroid cancer	4.07e-05	0.00422	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—RXRA—thyroid cancer	3.42e-05	0.00355	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—SLC5A5—thyroid cancer	3.41e-05	0.00354	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—SLC5A5—thyroid cancer	3.31e-05	0.00344	CbGpPWpGaD
Azathioprine—XDH—Metabolism—TPR—thyroid cancer	3.29e-05	0.00342	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PRKAR1A—thyroid cancer	3.24e-05	0.00336	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PPARG—thyroid cancer	3.06e-05	0.00318	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—RXRA—thyroid cancer	2.86e-05	0.00297	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—RXRA—thyroid cancer	2.78e-05	0.00289	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PPARG—thyroid cancer	2.68e-05	0.00278	CbGpPWpGaD
Azathioprine—XDH—Metabolism—SLC5A5—thyroid cancer	2.46e-05	0.00256	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PTGS2—thyroid cancer	2.41e-05	0.0025	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PPARG—thyroid cancer	2.16e-05	0.00224	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PTGS2—thyroid cancer	2.1e-05	0.00219	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PTEN—thyroid cancer	2.1e-05	0.00218	CbGpPWpGaD
Azathioprine—XDH—Metabolism—RXRA—thyroid cancer	2.07e-05	0.00215	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PTEN—thyroid cancer	1.84e-05	0.00191	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PPARG—thyroid cancer	1.81e-05	0.00188	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PPARG—thyroid cancer	1.76e-05	0.00183	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PTGS2—thyroid cancer	1.7e-05	0.00176	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PTEN—thyroid cancer	1.48e-05	0.00154	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PTGS2—thyroid cancer	1.42e-05	0.00148	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PTGS2—thyroid cancer	1.38e-05	0.00144	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PPARG—thyroid cancer	1.31e-05	0.00136	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PTEN—thyroid cancer	1.24e-05	0.00129	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—AKT1—thyroid cancer	1.21e-05	0.00126	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PTEN—thyroid cancer	1.21e-05	0.00125	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—AKT1—thyroid cancer	1.06e-05	0.0011	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PTGS2—thyroid cancer	1.03e-05	0.00107	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PTEN—thyroid cancer	8.96e-06	0.000931	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—AKT1—thyroid cancer	8.53e-06	0.000885	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—AKT1—thyroid cancer	7.15e-06	0.000742	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—AKT1—thyroid cancer	6.95e-06	0.000722	CbGpPWpGaD
Azathioprine—XDH—Metabolism—AKT1—thyroid cancer	5.17e-06	0.000536	CbGpPWpGaD
